ALZ-507

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameALZ-507
Drug Alias NameALZ-507
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoprotein E4 modulators
TargetsApolipoprotein E4
Therapy Area/IndicationsMacular DegenerationAlzheimer DiseaseMyositis, Inclusion Body
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlzheon Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlzheon Inc
Inactive CompaniesN/A
Active IndicationsMacular DegenerationAlzheimer DiseaseMyositis, Inclusion Body
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A